Overview
The St. Jude Fellowship in Pediatric Cancer Predisposition offers training in germline precision medicine, which holds great promise to optimize the clinical care of children with cancer. As such, it is critical that pediatric hematology/oncology practitioners understand and learn how to incorporate recent exciting yet complex discoveries surrounding germline genomics into the daily management of their patients.
As a fellow, you will:
- Enhance your clinical expertise in the diagnosis and evaluation of infants, children, adolescents, and young adults with hereditary cancer predisposition syndromes.
- Develop a multidisciplinary approach to the management of individuals affected by hereditary cancer predisposition.
- Apply knowledge obtained from tumor and germline genomic testing to understand mechanisms underlying cancer risk, tumor formation, and impacts on cancer treatment for patients with hereditary predisposition to cancer.
This one-year program provides fellows with advanced training in cancer genetics as well as ample research opportunities focused on hereditary predisposition to cancer.
Eligibility
Candidates should be American Board of Pediatrics eligible for pediatric hematology-oncology or should have received equivalent training as judged by the program directors.
To Apply
To apply, contact program director Kim E. Nichols, MD, at kim.nichols@stjude.org.
Learn More
Learn more about the Cancer Predisposition program.